really good presentation, lots of new data points, very considerate and enlightening for shareholders regarding the platform technology as a whole; key takeaway that market focus on PYC values derived from individual leads, such as VP-001, will diminish in 2022 as new leads come to the fore - demonstrating potency of PYC tech.
regarding CNS - Rohan mentioned ALS is of interest (am very excited that PYC is tackling this) - and activity aligns with the discovery team hiring a:
Scientific Research Assistant - Histology
https://www.seek.com.au/RNA-jobs/in-Perth-CBD,-Inner-&-Western-Suburbs-Perth-WA
Ann: 2021 AGM Chairman's Address and CEO Presentation, page-8
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $909.8M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.8¢ | $481.0K | 2.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 171122 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 122145 | 4 |
View Market Depth
| Last trade - 10.33am 16/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |